THERAVEX Tissue Care Spray Plus for the Management of Cutaneous Wounds, Burns, and Chronic Ulcers

Pilot observational clinical evaluation assessing the safety and potential effectiveness of THERAVEX Tissue Care Spray Plus as an adjunctive topical therapy for the management of cutaneous wounds, burns, traumatic lesions, pressure ulcers, diabetic ulcers, and chronic ulcers in 26 patients. The study evaluated wound healing progression, epithelialization, tissue hydration, inflammatory response, tolerance, and overall clinical evolution in patients receiving standard wound care combined with topical application of THERAVEX Tissue Care Spray Plus. Preliminary observations demonstrated favorable tissue response, progressive epithelial regeneration, reduction of inflammatory signs, and absence of treatment-related adverse events.

NCT Number	NCT07617961
Lead Sponsor	Biointelligent Technology Systems SL Collaborators: Sohag University
Conditions	Chronic Wounds, Burns, Pressure Ulcer, Traumatic Wounds, Diabetic Foot Ulcer
Enrollment	26 participants
Start Date	2025-10-02
Primary Completion	2025-11-15 (estimated)
Study Completion	2027-05-21 (estimated)
Updated on ClinicalTrials.gov	2026-06-04